Muscarinic antagonists
AssigneeSchering Corporation
InventorsJohn W. Clader, Joseph A. Kozlowski, Stuart W. McCombie, Michael W. Miller, Susan F. Vice
Life of this patent
Estimating the term…
Loading patent…
AssigneeSchering Corporation
InventorsJohn W. Clader, Joseph A. Kozlowski, Stuart W. McCombie, Michael W. Miller, Susan F. Vice
Estimating the term…
Amide derivatives of 1,4 di-substituted piperidine compounds of the formula or a pharmaceutically acceptable salt, ester or solvate thereof, wherein Q and Q1 are each —CH═, or one of Q and Q1 is —CH═ and the other is —N═; X is —CH2— or Y and Z are —C(R5)═, or one of Y and Z is —C(R5)═ and the other is —N═; R1 is 1 to 3 substituents selected from H, halogen and alkoxy; R2 and R5 are 1 to 3 substituents selected from H, halogen, alkyl and alkoxy; and R3 and R4 are H or (C1-C6)alkyl are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed.
A compound having the structural formula
18.
Dependencies are inferred from the claim text.